Log in
Enquire now
‌

US Patent 9629881 Bacteriotherapy for clostridium difficile colitis

Patent 9629881 was granted and assigned to Rebiotix on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Rebiotix
Rebiotix
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96298810
Patent Inventor Names
Edwin J. Hlavka0
Date of Patent
April 25, 2017
0
Patent Application Number
135765730
Date Filed
February 1, 2011
0
Patent Citations Received
‌
US Patent 11944654 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 12102655 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 12083150 Microbiota restoration therapy (MRT), composition and methods of manufacture
0
‌
US Patent 11986500 Bacteriotherapy for clostridium difficile colitis
0
Patent Primary Examiner
‌
Jonathan K Ng
0
Patent abstract

This document discusses, among other things, receiving a plurality of donor fecal samples from a plurality of donors and storing and indexing each respective donor fecal samples using at least one characteristic of the respective donor fecal sample. In an example, the donor fecal sample can be screened and processed for subsequent use in fecal bacteriotherapy to displace pathogenic or undesired organisms in the digestive track of a patient with healthy or desirable gut micriobiota.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9629881 Bacteriotherapy for clostridium difficile colitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.